Brief: Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results And Provides Corporate Update

Kiniksa Pharmaceuticals International

03/08/2022 13:08

Aug 3 (Reuters) - Kiniksa Pharmaceuticals Ltd  KNSA.O :
    * KINIKSA PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * SEES FY REVENUE $115 MILLION TO $130 MILLION
    * ARCALYST FULL-YEAR 2022 NET REVENUE EXPECTED TO BE $115 -
$130
MILLION
    * KINIKSA PHARMA SEES CASH,CASH EQUIVALENTS TO FUND CURRENT
OPERATING PLAN INTO AT LEAST 2025 AFTER CLOSE OF VIXARELIMAB
GLOBAL LICENSE AGREEMENT
    * QTRLY LOSS PER SHARE $0.29

Source text for Eikon:  ID:nGNX907L3h 
Further company coverage:  KNSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))